Hardware, Equipment & Parts
Compare Stocks
2 / 10Stock Comparison
FN vs CLS
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
FN vs CLS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Hardware, Equipment & Parts | Hardware, Equipment & Parts |
| Market Cap | $24.33B | $47.58B |
| Revenue (TTM) | $4.24B | $13.81B |
| Net Income (TTM) | $418M | $960M |
| Gross Margin | 12.0% | 11.6% |
| Operating Margin | 9.9% | 7.8% |
| Forward P/E | 49.9x | 41.2x |
| Total Debt | $9M | $914M |
| Cash & Equiv. | $306M | $595M |
FN vs CLS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Fabrinet (FN) | 100 | 1062.1 | +962.1% |
| Celestica Inc. (CLS) | 100 | 6104.3 | +6004.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FN vs CLS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FN is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 2.74
- Lower volatility, beta 2.74, Low D/E 0.5%, current ratio 3.00x
- Beta 2.74, current ratio 3.00x
CLS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 30.7%, EPS growth 101.9%, 3Y rev CAGR 20.3%
- 39.7% 10Y total return vs FN's 18.7%
- PEG 0.56 vs FN's 2.00
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 30.7% revenue growth vs FN's 18.6% | |
| Value | Lower P/E (41.2x vs 49.9x), PEG 0.56 vs 2.00 | |
| Quality / Margins | 9.9% margin vs CLS's 6.9% | |
| Stability / Safety | Beta 2.74 vs CLS's 2.75, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +334.8% vs FN's +231.5% | |
| Efficiency (ROA) | 13.6% ROA vs FN's 13.3%, ROIC 34.0% vs 16.1% |
FN vs CLS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FN vs CLS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — FN and CLS each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLS is the larger business by revenue, generating $13.8B annually — 3.3x FN's $4.2B. Profitability is closely matched — net margins range from 9.9% (FN) to 6.9% (CLS). On growth, CLS holds the edge at +52.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4.2B | $13.8B |
| EBITDAEarnings before interest/tax | $432M | $1.2B |
| Net IncomeAfter-tax profit | $418M | $960M |
| Free Cash FlowCash after capex | $46M | $493M |
| Gross MarginGross profit ÷ Revenue | +12.0% | +11.6% |
| Operating MarginEBIT ÷ Revenue | +9.9% | +7.8% |
| Net MarginNet income ÷ Revenue | +9.9% | +6.9% |
| FCF MarginFCF ÷ Revenue | +1.1% | +3.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +39.3% | +52.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +54.0% | +147.3% |
Valuation Metrics
CLS leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 56.8x trailing earnings, CLS trades at a 23% valuation discount to FN's 74.1x P/E. Adjusting for growth (PEG ratio), CLS offers better value at 0.78x vs FN's 2.97x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $24.3B | $47.6B |
| Enterprise ValueMkt cap + debt − cash | $24.0B | $47.9B |
| Trailing P/EPrice ÷ TTM EPS | 74.06x | 56.77x |
| Forward P/EPrice ÷ next-FY EPS est. | 49.87x | 41.25x |
| PEG RatioP/E ÷ EPS growth rate | 2.97x | 0.78x |
| EV / EBITDAEnterprise value multiple | 63.60x | 37.78x |
| Price / SalesMarket cap ÷ Revenue | 7.12x | 3.77x |
| Price / BookPrice ÷ Book value/share | 12.43x | 21.74x |
| Price / FCFMarket cap ÷ FCF | 117.79x | 102.04x |
Profitability & Efficiency
CLS leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
CLS delivers a 47.7% return on equity — every $100 of shareholder capital generates $48 in annual profit, vs $20 for FN. FN carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CLS's 0.41x. On the Piotroski fundamental quality scale (0–9), CLS scores 7/9 vs FN's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +19.6% | +47.7% |
| ROA (TTM)Return on assets | +13.3% | +13.6% |
| ROICReturn on invested capital | +16.1% | +34.0% |
| ROCEReturn on capital employed | +17.1% | +34.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.00x | 0.41x |
| Net DebtTotal debt minus cash | -$297M | $320M |
| Cash & Equiv.Liquid assets | $306M | $595M |
| Total DebtShort + long-term debt | $9M | $914M |
| Interest CoverageEBIT ÷ Interest expense | — | 21.51x |
Total Returns (Dividends Reinvested)
CLS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CLS five years ago would be worth $506,572 today (with dividends reinvested), compared to $78,753 for FN. Over the past 12 months, CLS leads with a +334.8% total return vs FN's +231.5%. The 3-year compound annual growth rate (CAGR) favors CLS at 2.3% vs FN's 93.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +41.6% | +36.9% |
| 1-Year ReturnPast 12 months | +231.5% | +334.8% |
| 3-Year ReturnCumulative with dividends | +626.4% | +3615.2% |
| 5-Year ReturnCumulative with dividends | +687.5% | +4965.7% |
| 10-Year ReturnCumulative with dividends | +1868.9% | +3965.5% |
| CAGR (3Y)Annualised 3-year return | +93.7% | +2.3% |
Risk & Volatility
Evenly matched — FN and CLS each lead in 1 of 2 comparable metrics.
Risk & Volatility
FN is the less volatile stock with a 2.74 beta — it tends to amplify market swings less than CLS's 2.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.74x | 2.75x |
| 52-Week HighHighest price in past year | $733.00 | $435.00 |
| 52-Week LowLowest price in past year | $193.54 | $90.00 |
| % of 52W HighCurrent price vs 52-week peak | +92.6% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 52.0 | 63.9 |
| Avg Volume (50D)Average daily shares traded | 697K | 2.0M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates FN as "Buy" and CLS as "Buy". Consensus price targets imply 10.9% upside for CLS (target: $459) vs -9.5% for FN (target: $615).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $614.50 | $459.00 |
| # AnalystsCovering analysts | 24 | 27 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 2 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | +0.8% |
CLS leads in 3 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 2 categories are tied.
FN vs CLS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is FN or CLS a better buy right now?
For growth investors, Celestica Inc.
(CLS) is the stronger pick with 30. 7% revenue growth year-over-year, versus 18. 6% for Fabrinet (FN). Celestica Inc. (CLS) offers the better valuation at 56. 8x trailing P/E (41. 2x forward), making it the more compelling value choice. Analysts rate Fabrinet (FN) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FN or CLS?
On trailing P/E, Celestica Inc.
(CLS) is the cheapest at 56. 8x versus Fabrinet at 74. 1x. On forward P/E, Celestica Inc. is actually cheaper at 41. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Celestica Inc. wins at 0. 56x versus Fabrinet's 2. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FN or CLS?
Over the past 5 years, Celestica Inc.
(CLS) delivered a total return of +49. 7%, compared to +687. 5% for Fabrinet (FN). Over 10 years, the gap is even starker: CLS returned +39. 7% versus FN's +1869%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FN or CLS?
By beta (market sensitivity over 5 years), Fabrinet (FN) is the lower-risk stock at 2.
74β versus Celestica Inc. 's 2. 75β — meaning CLS is approximately 0% more volatile than FN relative to the S&P 500. On balance sheet safety, Fabrinet (FN) carries a lower debt/equity ratio of 0% versus 41% for Celestica Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FN or CLS?
By revenue growth (latest reported year), Celestica Inc.
(CLS) is pulling ahead at 30. 7% versus 18. 6% for Fabrinet (FN). On earnings-per-share growth, the picture is similar: Celestica Inc. grew EPS 101. 9% year-over-year, compared to 13. 2% for Fabrinet. Over a 3-year CAGR, CLS leads at 20. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FN or CLS?
Fabrinet (FN) is the more profitable company, earning 9.
7% net margin versus 6. 7% for Celestica Inc. — meaning it keeps 9. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FN leads at 9. 5% versus 8. 6% for CLS. At the gross margin level — before operating expenses — FN leads at 12. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FN or CLS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Celestica Inc. (CLS) is the more undervalued stock at a PEG of 0. 56x versus Fabrinet's 2. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Celestica Inc. (CLS) trades at 41. 2x forward P/E versus 49. 9x for Fabrinet — 8. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLS: 10. 9% to $459. 00.
08Which pays a better dividend — FN or CLS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is FN or CLS better for a retirement portfolio?
For long-horizon retirement investors, Fabrinet (FN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1869% 10Y return).
Celestica Inc. (CLS) carries a higher beta of 2. 75 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FN: +1869%, CLS: +39. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FN and CLS?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.